Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies

α-Synuclein (asyn) is a key pathogenetic factor in a group of neurodegenerative diseases generically known as synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). Although the initial triggers of pathology and progression are...

Full description

Bibliographic Details
Main Authors: Sindhu Menon, Sabrina Armstrong, Amir Hamzeh, Naomi P. Visanji, Sergio Pablo Sardi, Anurag Tandon
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Neurology
Subjects:
Parkinson's disease
prion
gene therapy
anti-aggregation
brain delivery of drugs
immunization
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.852003/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.852003/full

Similar Items